rs62638634
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001034853.2(RPGR):c.179G>T(p.Gly60Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001034853.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPGR | ENST00000645032.1 | c.179G>T | p.Gly60Val | missense_variant | Exon 3 of 15 | NM_001034853.2 | ENSP00000495537.1 | |||
ENSG00000250349 | ENST00000465127.1 | c.172-343200C>A | intron_variant | Intron 3 of 8 | 5 | ENSP00000417050.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:2Other:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23536988, 10937588, 28559085, 10958647, 19815619, 20631154, 23213406, 38586605, 34985506, 9399904, 9855162) -
The RPGR c.179G>T; p.Gly60Val variant (rs62638634) has been reported in several individuals with X-linked retinitis pigmentosa (Buraczynska 1997, Sharon 2000, Stone 2017) and has been reported to segregate with disease in at least one family (Fishman 1998). The variant is reported in the ClinVar database (Variation ID: 9902) but is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The glycine at codon 60 is highly conserved, computational algorithms (PolyPhen-2, SIFT) predict this variant is deleterious, and structural analysis predicts this amino acid is critical in protein function and the variant causes reduced protein interaction (Patil 2012). Considering available information, this variant is classified as pathogenic. References: Buraczynska M et al. Spectrum of mutations in the RPGR gene that are identified in 20% of families with X-linked retinitis pigmentosa. Am J Hum Genet. 1997 Dec;61(6):1287-92. Fishman GA et al. X-linked retinitis pigmentosa in two families with a missense mutation in the RPGR gene and putative change of glycine to valine at codon 60. Ophthalmology. 1998 Dec;105(12):2286-96. Patil H et al. Structural and functional plasticity of subcellular tethering, targeting and processing of RPGRIP1 by RPGR isoforms. Biol Open. 2012 Feb 15;1(2):140-60. Sharon D et al. X-linked retinitis pigmentosa: mutation spectrum of the RPGR and RP2 genes and correlation with visual function. Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2712-21. Stone EM et al. Clinically Focused Molecular Investigation of 1000 Consecutive Families with Inherited Retinal Disease. Ophthalmology. 2017 Sep;124(9):1314-1331. -
- -
RPGR-related disorder Pathogenic:1
The RPGR c.179G>T variant is predicted to result in the amino acid substitution p.Gly60Val. This variant has been reported in individuals with retinitis pigmentosa (Buraczynska et al. 1997. PubMedID: 9399904; Sharon et al. 2003. PubMed ID: 14564670; Table S3, Tuupanen et al. 2022. PubMed ID: 34985506). An in silico functional study suggests this variant causes misfolding of a particular domain of the protein (Patil et al. 2012. PubMed ID: 23213406). This variant has been classified as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/9902/). Given the evidence, we interpret this variant as pathogenic. -
Retinitis pigmentosa 3 Pathogenic:1
- -
Primary ciliary dyskinesia Pathogenic:1
This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 60 of the RPGR protein (p.Gly60Val). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with retinitis pigmentosa (PMID: 9399904, 9855162, 10937588). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 9902). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RPGR protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change does not substantially affect RPGR function (PMID: 19815619, 20631154). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Retinal dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at